Literature DB >> 10171144

An investigation of bioactive glass powders by sol-gel processing.

R Li1, A E Clark, L L Hench.   

Abstract

Bioactive glass powders, with a composition of SiO 2-CaO-P 2O 5, have been successfully synthesized via a sol-gel process at considerably lower temperatures than required for conventional melting methods. Bioactive glass powders made via conventional methods form an interfacial bond with bone when they are implanted. Bonding is correlated with the formation of a surface hydroxyapatite layer. This study examined the formation of a hydroxyapatite layer in Tris-buffered solution as a function of SiO 2 content of sol-gel derived powders. A FT-IRRS technique was used to monitor the formation of the hydroxyapatite on the surface of the powders. X-ray diffraction analysis and BET were also used to characterize the chemical and physical properties of the sol-gel derived bioactive powders. It was discovered that: (a) the rate of hydroxyapatite formation decreased with increasing SiO 2 content for powders whose SiO 2 content was less than 90 mol%; (b) a hydroxyapatite film does not form for the powders whose SiO 2 content is more than 90 mol%; (c) the SiO 2 limit, beyond which the powders lost their bioactivity, was much higher for bioactive glass powders made through sol-gel process (90%) than those made by conventional melting methods (60%). These results indicate that it is possible to significantly expand the bioactive composition range through microstructural control made possible by sol-gel processing techniques.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 10171144     DOI: 10.1002/jab.770020403

Source DB:  PubMed          Journal:  J Appl Biomater        ISSN: 1045-4861


  45 in total

1.  A microstructural examination of apatite induced by Bioglass in vitro.

Authors:  J P Zhong; D C Greenspan; J W Feng
Journal:  J Mater Sci Mater Med       Date:  2002-03       Impact factor: 3.896

2.  Fibroblast growth and polymorphonuclear granulocyte activation in the presence of a new biologically active sol-gel glass.

Authors:  G Palumbo; L Avigliano; G Strukul; F Pinna; D Del Principe; I D'Angelo; M Annicchiarico-Petruzzelli; B Locardi; N Rosato
Journal:  J Mater Sci Mater Med       Date:  1997-07       Impact factor: 3.896

Review 3.  Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review.

Authors:  Jasmin Hum; Aldo R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2012-02-24       Impact factor: 3.896

4.  The story of Bioglass.

Authors:  Larry L Hench
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

5.  Controlling ion release from bioactive glass foam scaffolds with antibacterial properties.

Authors:  Julian R Jones; Lisa M Ehrenfried; Priya Saravanapavan; Larry L Hench
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

Review 6.  From the bioactive glasses to the star gels.

Authors:  María Vallet-Regí; Antonio J Salinas; Daniel Arcos
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

Review 7.  Promising trends of bioceramics in the biomaterials field.

Authors:  D Arcos; I Izquierdo-Barba; M Vallet-Regí
Journal:  J Mater Sci Mater Med       Date:  2008-11-06       Impact factor: 3.896

8.  Sol-gel derived 45S5 bioglass: synthesis, microstructural evolution and thermal behaviour.

Authors:  Ilaria Cacciotti; Mariangela Lombardi; Alessandra Bianco; Antonio Ravaglioli; Laura Montanaro
Journal:  J Mater Sci Mater Med       Date:  2012-05-12       Impact factor: 3.896

9.  Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application.

Authors:  Chengtie Wu; Jiang Chang
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

10.  Physical and cytocompatibility properties of bioactive glass-polyvinyl alcohol-sodium alginate biocomposite foams prepared via sol-gel processing for trabecular bone regeneration.

Authors:  Ruchi Mishra; Bikramjit Basu; Ashok Kumar
Journal:  J Mater Sci Mater Med       Date:  2009-12       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.